Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRentokil Initial Regulatory News (RTO)

Share Price Information for Rentokil Initial (RTO)

Share Price is delayed by 15 minutes
Get Live Data
429.30    0.30 (0.07%)
Bid:
428.60
Ask:
428.90
Spread: 0.30 (0.07%)
Market Cap: £10.80b
RTO Live PriceLast checked at - London Stock Exchange

Intraday Rentokil Initial Share Chart

Q3 Trading Update

5 Nov 2015 07:00

RNS Number : 6149E
Rentokil Initial PLC
05 November 2015
 



  

RENTOKIL INITIAL PLC (RTO)

THIRD QUARTER (Q3) TRADING UPDATE

5 November 2015

 

Results

Q3 2015

Growth

YTD 2015

Growth

£m

AER

AER

CER

AER

AER

CER

Revenue

438.0

(0.4%)

4.1%

1,293.3

-

4.3%

Revenue - ongoing operations1

436.2

0.3%

4.8%

1,287.2

0.7%

5.1%

 

 

Overview (CER)Revenue from ongoing operations increased by 4.8% in the quarter. Q3 organic revenue growth was in line with the second quarter at 1.4% with 3.4% growth from acquisitions. Growth in the Emerging (+11.1%) and Growth (+9.3%) quadrants was strong, with revenue in the Protect and Enhance (-1.4%) and Manage for Value (-4.7%) quadrants down on last year. Revenue from ongoing operations for the nine months ended 30 September 2015 ("year-to-date") increased by 5.1% with organic growth of 1.7% and 3.4% from acquisitions.

Performance continues to be strong in the UK, North America, Asia, Pacific and Latin America driven by continued strong growth in pest control. While conditions remain difficult in France and the Netherlands, year-to-date ongoing revenue in the Europe region is in line with last year.

Cash flowYear-to-date operating and free cash flow are ahead of the prior year and we are confident of delivering free cash flow for the year in excess of £100m.

M&AIn Q3 we acquired five businesses, all in pest control in our Emerging and Growth quadrants. Combined annual revenues of the businesses acquired totalled £17m in the 12 months immediately prior to acquisition. Year-to-date we have acquired 19 businesses with combined annual revenues of £38m. As previously announced our acquisition of The Steritech Group Inc completed on 2nd October and the process of integration is underway and on track.

Commenting on trading in Q3, Andy Ransom, CEO of Rentokil Initial plc, said:"We continue to execute our strategy at pace with the recent acquisition of Steritech providing us with a high quality business with national scale in a key growth market. The performance in the majority of the group continues to be strong although trading in Europe, France in particular, remains challenging. Our guidance for the full year is unchanged."

 

 

Enquiries:

 

Investors / Analysts:

Katharine Rycroft

Rentokil Initial plc

01276 536585 / 07811 270734

Media:

Malcolm Padley

Rentokil Initial plc

07788 978 199

John Sunnucks

Bell Pottinger

0203 772 2549

 

 

 

AER - actual exchange rates; CER - constant 2014 exchange rates

 

1ongoing revenue excludes the financial performance of disposed and closed businesses but includes results from acquisitions

 

This announcement contains statements that are, or may be, forward-looking regarding the group's financial position and results, business strategy, plans and objectives. Such statements involve risk and uncertainty because they relate to future events and circumstances and there are accordingly a number of factors which might cause actual results and performance to differ materially from those expressed or implied by such statements. Forward-looking statements speak only as of the date they are made and no representation or warranty, whether expressed or implied, is given in relation to them, including as to their completeness or accuracy or the basis on which they were prepared. Other than in accordance with the Company's legal or regulatory obligations (including under the Listing Rules and the Disclosure and Transparency Rules), the Company does not undertake any obligation to update or revise publicly any forward-looking statement, whether as a result of new information, future events or otherwise. Information contained in this announcement relating to the Company or its share price, or the yield on its shares, should not be relied upon as an indicator of future performance. Nothing in this announcement should be construed as a profit forecast.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTKMMGMNDRGKZM
Date   Source Headline
14th Oct 200812:52 pmRNS?50m Floating Rate Notes due 2013
14th Oct 200810:53 amRNSHolding(s) in Company
8th Oct 20082:59 pmRNSHolding(s) in Company
29th Sep 20082:17 pmRNSPublication of Prospectus
25th Sep 200812:50 pmRNS?75,000,000 Floating Rate Reset Notes due 2033
15th Sep 20082:56 pmRNSHolding(s) in Company
15th Sep 20082:45 pmRNSDirector/PDMR Shareholding
15th Sep 200810:44 amRNSEvaluation of potential sterling bond
4th Sep 200812:23 pmRNSHolding(s) in Company
28th Aug 20085:22 pmRNSDirector/PDMR Shareholding
22nd Aug 20087:00 amRNSInterim Results
21st Aug 20084:26 pmRNSHolding(s) in Company
18th Aug 200810:40 amRNSHolding(s) in Company
14th Aug 20083:33 pmRNSHolding(s) in Company
12th Aug 200810:10 amRNSHolding(s) in Company
4th Aug 200812:48 pmRNSHolding(s) in Company
31st Jul 200812:51 pmRNSHolding(s) in Company
28th Jul 200811:49 amRNSHolding(s) in Company
25th Jul 20087:00 amRNSTrading Statement
11th Jul 20084:24 pmRNSHolding(s) in Company
27th Jun 20084:35 pmRNSHolding(s) in Company
26th Jun 200812:39 pmRNSDirector/PDMR Shareholding
26th Jun 200812:23 pmRNSDirector/PDMR Shareholding
20th Jun 20082:45 pmRNSHolding(s) in Company
17th Jun 20084:24 pmRNSHolding(s) in Company
17th Jun 20084:18 pmRNSHolding(s) in Company
13th Jun 200811:15 amRNSPublication of Prospectus
22nd May 20085:05 pmRNSAnnual Information Update
14th May 20084:46 pmRNSAGM Statement
14th May 20087:00 amRNSPublication of Prospectus
2nd May 20087:00 amRNSQ1 2008 Trading Update
29th Apr 20085:16 pmRNSHolding(s) in Company
24th Apr 200811:16 amRNSHolding(s) in Company
23rd Apr 20081:19 pmRNSHolding(s) in Company
21st Apr 20087:01 amRNSCity Link Update
15th Apr 20089:43 amRNSAnnual Report and Accounts
9th Apr 200811:50 amRNSHolding(s) in Company
3rd Apr 200810:32 amRNSHolding(s) in Company
26th Mar 200810:59 amRNSHolding(s) in Company
20th Mar 20089:58 amPRNExternal Directorship
20th Mar 20087:01 amRNSDirectorate Change
11th Mar 20083:43 pmRNSHolding(s) in Company
5th Mar 200811:12 amRNSHolding(s) in Company
3rd Mar 200812:02 pmRNSHolding(s) in Company
28th Feb 20083:11 pmRNSDirector/PDMR Shareholding
28th Feb 20087:02 amRNSDirectorate Change
28th Feb 20087:02 amRNSFinal Results
15th Feb 200811:01 amRNSDirectorate Change
30th Jan 200812:21 pmRNSHolding(s) in Company
14th Jan 200811:08 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.